AbbVie to buy Botox-maker Allergan in $63 billion deal AbbVie said today it would buy Botox-maker Allergan in a cash-and-stock deal for about $63 billion to add fast-growing therapeutic businesses such as medical aesthetics … Business • 25 Jun 19
Allergan raises 2019 forecasts as Botox boosts results Allergan today raised its profit and revenue forecasts for the year as it beat expectations for quarterly profit, fueled by higher sales of its blockbuster … Business • 07 May 19
